Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

RegCell lands $44M Series A to take Nobel-winning Tregs into clinic

For nearly 50 years, Shimon Sakaguchi has been studying and working on regulatory T cells, figuring out how the immune system "governs itself." Now, the Nobel laureate's decade-old biotech RegCell is gearing up for clinical ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 15 September →